'en:yttrium 90 therapy'
(id=7286885 ; fe=en:yttrium 90 therapy ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=617 creation date=2017-06-26 touchdate=2024-09-20 01:32:09.000) ≈ 26 relations sortantes
- en:yttrium 90 therapy --
r_associated #0: 37 / 1 ->
en:preload cavity radiotherapy - sealed
n1=en:yttrium 90 therapy | n2=en:preload cavity radiotherapy - sealed | rel=r_associated | relid=0 | w=37
- en:yttrium 90 therapy --
r_associated #0: 35 / 0.946 ->
en:internal metabolic radiotherapy
n1=en:yttrium 90 therapy | n2=en:internal metabolic radiotherapy | rel=r_associated | relid=0 | w=35
- en:yttrium 90 therapy --
r_associated #0: 34 / 0.919 ->
en:interstitial radioactive colloid therapy
n1=en:yttrium 90 therapy | n2=en:interstitial radioactive colloid therapy | rel=r_associated | relid=0 | w=34
- en:yttrium 90 therapy --
r_associated #0: 34 / 0.919 ->
en:radionuclide therapy for glandular suppression
n1=en:yttrium 90 therapy | n2=en:radionuclide therapy for glandular suppression | rel=r_associated | relid=0 | w=34
- en:yttrium 90 therapy --
r_associated #0: 32 / 0.865 ->
en:cesium 137 brachytherapy
n1=en:yttrium 90 therapy | n2=en:cesium 137 brachytherapy | rel=r_associated | relid=0 | w=32
- en:yttrium 90 therapy --
r_associated #0: 32 / 0.865 ->
en:intravascular radionuclide therapy
n1=en:yttrium 90 therapy | n2=en:intravascular radionuclide therapy | rel=r_associated | relid=0 | w=32
- en:yttrium 90 therapy --
r_associated #0: 32 / 0.865 ->
en:radionuclide rhenium 186 hydroxyethylidene diphosphonate therapy
n1=en:yttrium 90 therapy | n2=en:radionuclide rhenium 186 hydroxyethylidene diphosphonate therapy | rel=r_associated | relid=0 | w=32
- en:yttrium 90 therapy --
r_associated #0: 32 / 0.865 ->
en:selective internal radiotherapy to lesion of liver using microspheres
n1=en:yttrium 90 therapy | n2=en:selective internal radiotherapy to lesion of liver using microspheres | rel=r_associated | relid=0 | w=32
- en:yttrium 90 therapy --
r_associated #0: 31 / 0.838 ->
en:intracavitary radiation therapy
n1=en:yttrium 90 therapy | n2=en:intracavitary radiation therapy | rel=r_associated | relid=0 | w=31
- en:yttrium 90 therapy --
r_associated #0: 31 / 0.838 ->
en:mold technique gamma/beta
n1=en:yttrium 90 therapy | n2=en:mold technique gamma/beta | rel=r_associated | relid=0 | w=31
- en:yttrium 90 therapy --
r_associated #0: 30 / 0.811 ->
en:beta source contact therapy
n1=en:yttrium 90 therapy | n2=en:beta source contact therapy | rel=r_associated | relid=0 | w=30
- en:yttrium 90 therapy --
r_associated #0: 30 / 0.811 ->
en:radium therapy
n1=en:yttrium 90 therapy | n2=en:radium therapy | rel=r_associated | relid=0 | w=30
- en:yttrium 90 therapy --
r_associated #0: 29 / 0.784 ->
en:internal radiotherapy - unsealed source
n1=en:yttrium 90 therapy | n2=en:internal radiotherapy - unsealed source | rel=r_associated | relid=0 | w=29
- en:yttrium 90 therapy --
r_associated #0: 28 / 0.757 ->
en:brachytherapy using radioiodine
n1=en:yttrium 90 therapy | n2=en:brachytherapy using radioiodine | rel=r_associated | relid=0 | w=28
- en:yttrium 90 therapy --
r_associated #0: 28 / 0.757 ->
en:gold 198 therapy
n1=en:yttrium 90 therapy | n2=en:gold 198 therapy | rel=r_associated | relid=0 | w=28
- en:yttrium 90 therapy --
r_associated #0: 28 / 0.757 ->
en:peptide-mediated radionuclide therapy
n1=en:yttrium 90 therapy | n2=en:peptide-mediated radionuclide therapy | rel=r_associated | relid=0 | w=28
- en:yttrium 90 therapy --
r_associated #0: 27 / 0.73 ->
en:radionuclide implant therapy
n1=en:yttrium 90 therapy | n2=en:radionuclide implant therapy | rel=r_associated | relid=0 | w=27
- en:yttrium 90 therapy --
r_associated #0: 27 / 0.73 ->
en:ruthenium 106 brachytherapy
n1=en:yttrium 90 therapy | n2=en:ruthenium 106 brachytherapy | rel=r_associated | relid=0 | w=27
- en:yttrium 90 therapy --
r_associated #0: 27 / 0.73 ->
thérapie
n1=en:yttrium 90 therapy | n2=thérapie | rel=r_associated | relid=0 | w=27
- en:yttrium 90 therapy --
r_associated #0: 26 / 0.703 ->
en:radiolabeled antibody therapy
n1=en:yttrium 90 therapy | n2=en:radiolabeled antibody therapy | rel=r_associated | relid=0 | w=26
- en:yttrium 90 therapy --
r_associated #0: 26 / 0.703 ->
en:radionuclide therapy for hyperthyroidism
n1=en:yttrium 90 therapy | n2=en:radionuclide therapy for hyperthyroidism | rel=r_associated | relid=0 | w=26
- en:yttrium 90 therapy --
r_associated #0: 25 / 0.676 ->
en:yttrium
n1=en:yttrium 90 therapy | n2=en:yttrium | rel=r_associated | relid=0 | w=25
- en:yttrium 90 therapy --
r_associated #0: 20 / 0.541 ->
en:brachytherapy of breast
n1=en:yttrium 90 therapy | n2=en:brachytherapy of breast | rel=r_associated | relid=0 | w=20
- en:yttrium 90 therapy --
r_associated #0: 20 / 0.541 ->
en:radium contact therapy
n1=en:yttrium 90 therapy | n2=en:radium contact therapy | rel=r_associated | relid=0 | w=20
- en:yttrium 90 therapy --
r_associated #0: 20 / 0.541 ->
en:teleradiotherapy with radioactive cesium
n1=en:yttrium 90 therapy | n2=en:teleradiotherapy with radioactive cesium | rel=r_associated | relid=0 | w=20
- en:yttrium 90 therapy --
r_associated #0: 20 / 0.541 ->
en:therapeutic
n1=en:yttrium 90 therapy | n2=en:therapeutic | rel=r_associated | relid=0 | w=20
| ≈ 25 relations entrantes
- en:therapeutic ---
r_associated #0: 34 -->
en:yttrium 90 therapy
n1=en:therapeutic | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=34
- en:intracavitary radiation therapy ---
r_associated #0: 32 -->
en:yttrium 90 therapy
n1=en:intracavitary radiation therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=32
- en:radium contact therapy ---
r_associated #0: 31 -->
en:yttrium 90 therapy
n1=en:radium contact therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=31
- en:teleradiotherapy with radioactive cesium ---
r_associated #0: 31 -->
en:yttrium 90 therapy
n1=en:teleradiotherapy with radioactive cesium | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=31
- en:brachytherapy of breast ---
r_associated #0: 29 -->
en:yttrium 90 therapy
n1=en:brachytherapy of breast | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=29
- en:beta source contact therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:beta source contact therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:brachytherapy using radioiodine ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:brachytherapy using radioiodine | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:cesium 137 brachytherapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:cesium 137 brachytherapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:gold 198 therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:gold 198 therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:internal metabolic radiotherapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:internal metabolic radiotherapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:internal radiotherapy - unsealed source ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:internal radiotherapy - unsealed source | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:interstitial radioactive colloid therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:interstitial radioactive colloid therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:intravascular radionuclide therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:intravascular radionuclide therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:mold technique gamma/beta ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:mold technique gamma/beta | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:peptide-mediated radionuclide therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:peptide-mediated radionuclide therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:preload cavity radiotherapy - sealed ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:preload cavity radiotherapy - sealed | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:radiolabeled antibody therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:radiolabeled antibody therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:radionuclide implant therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:radionuclide implant therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:radionuclide rhenium 186 hydroxyethylidene diphosphonate therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:radionuclide rhenium 186 hydroxyethylidene diphosphonate therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:radionuclide therapy for glandular suppression ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:radionuclide therapy for glandular suppression | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:radionuclide therapy for hyperthyroidism ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:radionuclide therapy for hyperthyroidism | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:radium therapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:radium therapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:ruthenium 106 brachytherapy ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:ruthenium 106 brachytherapy | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- en:selective internal radiotherapy to lesion of liver using microspheres ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=en:selective internal radiotherapy to lesion of liver using microspheres | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
- thérapie ---
r_associated #0: 20 -->
en:yttrium 90 therapy
n1=thérapie | n2=en:yttrium 90 therapy | rel=r_associated | relid=0 | w=20
|